lobbying_activities: 2973062

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2973062	4c05cc3e-3f31-416e-bfa7-ef51e4964bd2	Q1	BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.	323876	BLUE CROSS AND BLUE SHIELD OF KANSAS INC	2023	first_quarter	PHA	INSULIN Act; Insulin Out of Pocket Charges; S. 148 - Stop STALLING Act Sponsor: Sen. Amy Klobuchar (D-MN) S. 142 - Preserve Access to Affordable Generics and Biosimilars Act Sponsor: Sen. Amy Klobuchar (D-MN) S. 150 - Affordable Prescriptions for Patients Act of 2023 Sponsor: Sen. John Comyn (R-TX) S. 127 - Pharmacy Benefit Manager Transparency Act of2023 Sponsor: Sen. Maria Cantwell (D-WA) S. 954 - Affordable Insulin Now Act of 2023 Sponsor: Sen. Raphael Warnock (D-GA)	Centers For Medicare and Medicaid Services (CMS),SENATE			0	0	2023-04-19T18:40:24-04:00